{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:39:02Z","timestamp":1794944342934,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minufiya University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Traumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Giant cell tumor of bone (GCTB) is a benign locally aggressive tumor frequently treated with intralesional curettage and cementation. The aim of this study was to investigate the long-term incidence of arthritic changes following curettage and cementation of GCTB around the knee.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>This study was a retrospective review of patients with GCTB around the knee treated with curettage and cementation with a minimum follow-up of 10\u00a0years. The functional results were assessed using the Musculoskeletal Tumor Society (MSTS) score. The arthritic changes were classified using the Kellgren\u2013Lawrence (KL) classification system of osteoarthritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study included 119 patients, 54 males and 65 females, with a mean age of 29.4\u2009\u00b1\u20099.2\u00a0years. There were 35 (29.4%) patients with pathological fractures. There were 84 (70.6%) patients with de novo lesions and 35 (29.4%) with recurrent lesions. The mean follow-up period was 13.2\u2009\u00b1\u20093.16\u00a0years. The mean MSTS score was 28.5\u2009\u00b1\u20091.9. Overall, 25 (21%) patients developed variable degrees of arthritis of KL grade 1 (<jats:italic>n<\/jats:italic>\u2009=\u20097), KL grade 2 (<jats:italic>n<\/jats:italic>\u2009=\u200911), KL grade 3 (<jats:italic>n<\/jats:italic>\u2009=\u20094), and KL grade 4 (<jats:italic>n<\/jats:italic>\u2009=\u20093). Ten patients showed progression of arthritis during the follow-up period. Age at presentation, gender, presence of pathological fracture, whether the tumor was de novo or recurrent, and tumor location were not associated with arthritis incidence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Curettage and cementation can be used safely to treat GCTB around the knee. Arthritis of the knee is a possible complication, but mild grades are expected in most cases. There was no association between arthritis incidence and age, gender, pathological fractures, tumor location, or recurrent tumors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Level of evidence<\/jats:title><jats:p>Level IV.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s10195-023-00693-8","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T17:02:44Z","timestamp":1680800564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Incidence and progression of osteoarthritis following curettage and cementation of giant cell tumor of bone around the knee: long-term follow-up"],"prefix":"10.1186","volume":"24","author":[{"given":"Walid Atef","family":"Ebeid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail Tawfeek","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8047-9159","authenticated-orcid":false,"given":"Mohamed Kamal","family":"Mesregah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa Zakarya","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"693_CR1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.OA.19.00068","author":"Y Araki","year":"2020","unstructured":"Araki Y, Yamamoto N, Hayashi K, Takeuchi A, Miwa S, Igarashi K, Taniguchi Y, Yonezawa H, Morinaga S, Tsuchiya H (2020) Secondary osteoarthritis after curettage and calcium phosphate cementing for giant-cell tumor of bone around the knee joint: long-term follow-up. JBJS Open Access. https:\/\/doi.org\/10.2106\/JBJS.OA.19.00068","journal-title":"JBJS Open Access"},{"key":"693_CR2","doi-asserted-by":"publisher","first-page":"101499","DOI":"10.1016\/j.jcot.2021.101499","volume":"20","author":"WA Ebeid","year":"2021","unstructured":"Ebeid WA, Badr IT, Mesregah MK, Hasan BZ (2021) Risk factors and oncological outcomes of pulmonary metastasis in patients with giant cell tumor of bone. J Clin Orthop Trauma. 20:101499. https:\/\/doi.org\/10.1016\/j.jcot.2021.101499","journal-title":"J Clin Orthop Trauma."},{"issue":"7","key":"693_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/jso.25391","volume":"119","author":"S Tsukamoto","year":"2019","unstructured":"Tsukamoto S, Mavrogenis AF, Tanzi P, Leone G, Righi A, Akahane M, Kido A, Honoki K, Tanaka Y, Donati DM, Errani C (2019) Similar local recurrence but better function with curettage versus resection for bone giant cell tumor and pathological fracture at presentation. J Surg Oncol 119(7):864\u2013872. https:\/\/doi.org\/10.1002\/jso.25391","journal-title":"J Surg Oncol"},{"key":"693_CR4","doi-asserted-by":"publisher","first-page":"101817","DOI":"10.1016\/j.suronc.2022.101817","volume":"44","author":"C Wechsler","year":"2022","unstructured":"Wechsler C, Hodel S, Stern C, Laux CJ, Rosskopf AB, Muller DA (2022) Articular degeneration after subchondral cementation for giant cell tumors at the knee. Surg Oncol. 44:101817. https:\/\/doi.org\/10.1016\/j.suronc.2022.101817","journal-title":"Surg Oncol."},{"issue":"6","key":"693_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.otsr.2009.07.004","volume":"95","author":"N Fraquet","year":"2009","unstructured":"Fraquet N, Faizon G, Rosset P, Phillipeau J, Waast D, Gouin F (2009) Long bones giant cells tumors: treatment by curretage and cavity filling cementation. Orthop Traumatol Surg Res 95(6):402\u2013406. https:\/\/doi.org\/10.1016\/j.otsr.2009.07.004","journal-title":"Orthop Traumatol Surg Res"},{"issue":"7","key":"693_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.otsr.2017.06.013","volume":"103","author":"A Caubere","year":"2017","unstructured":"Caubere A, Harrosch S, Fioravanti M, Curvale G, Rochwerger A, Mattei JC (2017) Does curettage-cement packing for treating giant cell tumors at the knee lead to osteoarthritis? Orthop Traumatol Surg Res 103(7):1075\u20131079. https:\/\/doi.org\/10.1016\/j.otsr.2017.06.013","journal-title":"Orthop Traumatol Surg Res"},{"issue":"21","key":"693_CR7","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.2106\/JBJS.M.00066","volume":"95","author":"L van der Heijden","year":"2013","unstructured":"van der Heijden L, van de Sande MA, Heineken AC, Fiocco M, Nelissen RG, Dijkstra PD (2013) Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis? J Bone Joint Surg Am 95(21):e159. https:\/\/doi.org\/10.2106\/JBJS.M.00066","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"693_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2009.09.002","volume":"36","author":"C Errani","year":"2010","unstructured":"Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M (2010) Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev 36(1):1\u20137. https:\/\/doi.org\/10.1016\/j.ctrv.2009.09.002","journal-title":"Cancer Treat Rev"},{"key":"693_CR9","doi-asserted-by":"publisher","unstructured":"Zheng K, Yu XC, Hu YC, Wang Z, Wu SJ, Ye ZM, Giant Cell Tumor Group of China (2017) How to fill the cavity after curettage of giant cell tumors around the knee? A multicenter analysis. Chin Med J (Engl). 130(21):2541\u20132546. https:\/\/doi.org\/10.4103\/0366-6999.217093","DOI":"10.4103\/0366-6999.217093"},{"issue":"8","key":"693_CR10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jbiomech.2009.02.005","volume":"42","author":"BR Radev","year":"2009","unstructured":"Radev BR, Kase JA, Askew MJ, Weiner SD (2009) Potential for thermal damage to articular cartilage by PMMA reconstruction of a bone cavity following tumor excision: A finite element study. J Biomech 42(8):1120\u20131126. https:\/\/doi.org\/10.1016\/j.jbiomech.2009.02.005","journal-title":"J Biomech"},{"issue":"2","key":"693_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s007760200033","volume":"7","author":"T Wada","year":"2002","unstructured":"Wada T, Kaya M, Nagoya S, Kawaguchi S, Isu K, Yamashita T, Yamawaki S, Ishii S (2002) Complications associated with bone cementing for the treatment of giant cell tumors of bone. J Orthop Sci 7(2):194\u2013198. https:\/\/doi.org\/10.1007\/s007760200033","journal-title":"J Orthop Sci"},{"issue":"3","key":"693_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10195-016-0397-8","volume":"17","author":"SP Gupta","year":"2016","unstructured":"Gupta SP, Garg G (2016) Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones. J Orthop Traumatol 17(3):239\u2013247. https:\/\/doi.org\/10.1007\/s10195-016-0397-8","journal-title":"J Orthop Traumatol"},{"key":"693_CR13","first-page":"3","volume":"37","author":"WF Enneking","year":"1988","unstructured":"Enneking WF (1988) A system of staging musculoskeletal neoplasms. Instr Course Lect 37:3\u201310","journal-title":"Instr Course Lect"},{"issue":"4","key":"693_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494\u2013502. https:\/\/doi.org\/10.1136\/ard.16.4.494","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"693_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jcot.2019.09.017","volume":"10","author":"C Errani","year":"2019","unstructured":"Errani C, Tsukamoto S, Ciani G, Donati DM (2019) Present day controversies and consensus in curettage for giant cell tumor of bone. J Clin Orthop Trauma 10(6):1015\u20131020. https:\/\/doi.org\/10.1016\/j.jcot.2019.09.017","journal-title":"J Clin Orthop Trauma"},{"issue":"3","key":"693_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1302\/0301-620X.89B3.18604","volume":"89","author":"FV von Steyern","year":"2007","unstructured":"von Steyern FV, Kristiansson I, Jonsson K, Mannfolk P, Heinegard D, Rydholm A (2007) Giant-cell tumour of the knee: the condition of the cartilage after treatment by curettage and cementing. J Bone Joint Surg Br 89(3):361\u2013365. https:\/\/doi.org\/10.1302\/0301-620X.89B3.18604","journal-title":"J Bone Joint Surg Br"},{"issue":"45","key":"693_CR17","doi-asserted-by":"publisher","first-page":"13154","DOI":"10.1097\/MD.0000000000013154","volume":"97","author":"M Wu","year":"2018","unstructured":"Wu M, Yao S, Xie Y, Yan F, Deng Z, Lei J, Cai L (2018) A novel subchondral bone-grafting procedure for the treatment of giant-cell tumor around the knee: a retrospective study of 27 cases. Medicine (Baltimore) 97(45):13154. https:\/\/doi.org\/10.1097\/MD.0000000000013154","journal-title":"Medicine (Baltimore)"},{"key":"693_CR18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1750749","author":"L Lee","year":"2022","unstructured":"Lee L, Buac N, Colman MW, Gitelis S, Blank AT (2022) Total knee arthroplasty for osteoarthritis is uncommon after intralesional curettage in giant cell tumor of bone. J Knee Surg. https:\/\/doi.org\/10.1055\/s-0042-1750749","journal-title":"J Knee Surg"},{"issue":"6","key":"693_CR19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00590-017-1983-z","volume":"27","author":"C Errani","year":"2017","unstructured":"Errani C, Tsukamoto S, Leone G, Akahane M, Cevolani L, Tanzi P, Kido A, Honoki K, Tanaka Y, Donati DM (2017) Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites. Eur J Orthop Surg Traumatol 27(6):813\u2013819. https:\/\/doi.org\/10.1007\/s00590-017-1983-z","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"693_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/01.blo.0000180051.27961.c3","volume":"438","author":"RD Lackman","year":"2005","unstructured":"Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ (2005) Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop Relat Res 438:123\u2013127. https:\/\/doi.org\/10.1097\/01.blo.0000180051.27961.c3","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"693_CR21","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s11999-016-4755-x","volume":"475","author":"J Benevenia","year":"2017","unstructured":"Benevenia J, Rivero SM, Moore J, Ippolito JA, Siegerman DA, Beebe KS, Patterson FR (2017) Supplemental bone grafting in giant cell tumor of the extremity reduces nononcologic complications. Clin Orthop Relat Res 475(3):776\u2013783. https:\/\/doi.org\/10.1007\/s11999-016-4755-x","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"693_CR22","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1302\/0301-620X.93B12.27663","volume":"93","author":"CL Gaston","year":"2011","unstructured":"Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, Tillman RM, Grimer RJ (2011) Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br 93(12):1665\u20131669. https:\/\/doi.org\/10.1302\/0301-620X.93B12.27663","journal-title":"J Bone Joint Surg Br"},{"issue":"6","key":"693_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00264-006-0190-z","volume":"30","author":"K Szalay","year":"2006","unstructured":"Szalay K, Antal I, Kiss J, Szendroi M (2006) Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results. Int Orthop 30(6):505\u2013509. https:\/\/doi.org\/10.1007\/s00264-006-0190-z","journal-title":"Int Orthop"},{"issue":"2","key":"693_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00264-018-3939-2","volume":"43","author":"W Teng","year":"2019","unstructured":"Teng W, Lin P, Li Y, Yan X, Li H, Li B, Wang Z, Wu Y, Wang S, Zhou X, Wang Z, Ye Z (2019) Bone combined cement grafting in giant cell tumor around the knee reduces mechanical failure. Int Orthop 43(2):475\u2013482. https:\/\/doi.org\/10.1007\/s00264-018-3939-2","journal-title":"Int Orthop"},{"issue":"16","key":"693_CR25","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.3760\/cma.j.issn.0366-6999.20121150","volume":"126","author":"HR Xu","year":"2013","unstructured":"Xu HR, Niu XH, Zhang Q, Hao L, Ding Y, Li Y (2013) Subchondral bone grafting reduces degenerative change of knee joint in patients of giant cell tumor of bone. Chin Med J (Engl) 126(16):3053\u20133056","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"693_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2106\/JBJS.D.02771","volume":"90","author":"K Arbeitsgemeinschaft","year":"2008","unstructured":"Arbeitsgemeinschaft K, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU (2008) Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am 90(5):1060\u20131067. https:\/\/doi.org\/10.2106\/JBJS.D.02771","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"693_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00432-008-0427-x","volume":"135","author":"M Balke","year":"2009","unstructured":"Balke M, Ahrens H, Streitbuerger A, Koehler G, Winkelmann W, Gosheger G, Hardes J (2009) Treatment options for recurrent giant cell tumors of bone. J Cancer Res Clin Oncol 135(1):149\u2013158. https:\/\/doi.org\/10.1007\/s00432-008-0427-x","journal-title":"J Cancer Res Clin Oncol"},{"key":"693_CR28","doi-asserted-by":"publisher","unstructured":"Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM, Canadian Sarcoma Group (2002) Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res 397:248\u2013258. https:\/\/doi.org\/10.1097\/00003086-200204000-00029","DOI":"10.1097\/00003086-200204000-00029"},{"key":"693_CR29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amsu.2019.10.010","volume":"48","author":"O Hasan","year":"2019","unstructured":"Hasan O, Ali M, Mustafa M, Ali A, Umer M (2019) Treatment and recurrence of giant cell tumors of bone\u2014a retrospective cohort from a developing country. Ann Med Surg (Lond) 48:29\u201334. https:\/\/doi.org\/10.1016\/j.amsu.2019.10.010","journal-title":"Ann Med Surg (Lond)"},{"key":"693_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejca.2017.02.021","volume":"77","author":"L van der Heijden","year":"2017","unstructured":"van der Heijden L, Dijkstra PDS, Blay JY, Gelderblom H (2017) Giant cell tumour of bone in the denosumab era. Eur J Cancer 77:75\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.021","journal-title":"Eur J Cancer"}],"container-title":["Journal of Orthopaedics and Traumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10195-023-00693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10195-023-00693-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10195-023-00693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T21:27:10Z","timestamp":1729200430000},"score":1,"resource":{"primary":{"URL":"https:\/\/jorthoptraumatol.springeropen.com\/articles\/10.1186\/s10195-023-00693-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["693"],"URL":"https:\/\/doi.org\/10.1186\/s10195-023-00693-8","relation":{},"ISSN":["1590-9999"],"issn-type":[{"value":"1590-9999","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Menoufia University Institutional Review Board (IRB). Informed consent to participate in the study was taken from adult patients or the parents of minor patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish individual data was obtained from the patients or the parents of minor patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}